Interval starvation has positive health effects – as shown by a study by the "Interfast" researcher from Graz, which was published in the journal Metabolism of Cells on Tuesday afternoon.
In addition to weight loss, the so-called "alternative daily fasting" has a positive effect on health indicators, such as cholesterol, blood pressure, abdominal fat and inflammatory parameters.
Interval fasts are split into hours or days during a meal. During the investigation he did not eat one day, but the next day he ate without restriction. 60 healthy people were divided into two groups. One exercised occasionally for more than four weeks, while the other maintained her current lifestyle.
"The study was complemented by another 30 interviewees working on an alternative daily post for more than six months," explained study leader Frank Madeo of the University of Graz. The aim was to investigate the effects of intermittent fasting on body weight and on molecular mechanisms in healthy volunteers. Constant glucose monitoring was closely monitored by strict adherence to fasting.
A guarantee for a long life?
According to a report from the University of Graz, the results of the study show a clear picture: "The study participants reduced an average of about 3.5 kilograms of body weight within four weeks, with an average starting weight of 76 kilograms." In addition, there has been an increase in the number of ketone bodies. "They are produced as a by-product of fat burning in the absence of carbohydrates," the researchers said. These ketone bodies are believed to protect against aging.
"Furthermore, the fasting cohort showed a decrease in specific amino acid values, cholesterol, systolic blood pressure, abdominal fat or inflammatory parameters – all effects associated with positive health effects," Madeo said, summarizing the insights gained from molecular mechanisms.
In addition, in patients who were fasting, researchers found a slight decrease in thyroid hormone T3 with a concurrent increase in TSH-stimulating thyroid hormone, a status that has been associated with longevity in numerous studies.
Continuing on current results, the Interfast-2 study will begin in the fall, with intermittent fasting in patients with type 2 diabetes who already need insulin therapy. (Lop / SDA)
Created: 28.08.2019, 15:03 hour